Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) was the recipient of a large decline in short interest during the month of March. As of March 15th, there was short interest totalling 16,730,000 shares, a decline of 8.7% from the February 28th total of 18,330,000 shares. Based on an average daily volume of 2,760,000 shares, the […]
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 16,730,000 shares, a decline of 8.7% from the February 28th total of 18,330,000 shares. Based on an average daily trading volume, of 2,760,000 shares, […]
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) has received a consensus recommendation of “Moderate Buy” from the nine brokerages that are covering the company, Marketbeat.com reports. Three analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among analysts that have […]
/PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that...